How I Handle Retreatment of LUTS Following a Failed MIST. Review uri icon

Overview

abstract

  • PURPOSE OF REVIEW: The goal of this paper is to review retreatment management after failed minimally invasive treatment (MIST) of various technologies. RECENT FINDINGS: A failed MIST can be defined by the return, persistence, or worsening of LUTS, as documented by symptom scores. Persistence, development, or recurrence of comorbidities such as recurrent urinary tract infection (UTI), retention, stones, hematuria, and incontinence can also signal a failed MIST. The common etiology for MIST failure is the preoperative consequence of long-term bladder outlet obstruction (BOO) on the bladder function. Close monitoring of therapies with antimuscarinics or beta-agonists can be empirically utilized if post-void bladder residual (PVR) is low. If there is a high PVR, urodynamic studies and cystoscopy can be used to determine overactive bladder (OAB), BOO, or necrosis. Depending on the timing of the observed BOO/OAB, subsequent retreatments involving transurethral debridement, medical and behavioral therapies, or repeat surgical debulking can be employed.

publication date

  • June 11, 2021

Research

keywords

  • Minimally Invasive Surgical Procedures
  • Retreatment
  • Urinary Tract Infections

Identity

Scopus Document Identifier

  • 85107652251

Digital Object Identifier (DOI)

  • 10.1007/s11934-021-01054-w

PubMed ID

  • 34115242

Additional Document Info

volume

  • 22

issue

  • 8